Here are 16 key notes on orthopedic and spine device companies over the past week.
AlloSource received a patent for its new cartilage repair allograft, ProChondrix Cartilage Restoration Matrix.
Analysts expect Amedica to report revenue of $4.78 million for the fourth quarter.
Centinel Spine received FDA clearance for its ALTOS device.
Zacks analysts upgraded CONMED shares from a "hold" rating to a "buy" rating.
Technavio's new report shows that DePuy Synthes, Medtronic, NuVasive and Stryker are the top four leading vendors in the U.S. lateral lumbar interbody fusion market.
EOS imaging formed a new partnership with Montreal-based Spinologics.
Integra LifeSciences shares received a crowd sourced rating of four on a scale of one to five, on which five is a considered a "strong buy."
Johnson & Johnson plans to cut about 3,000 jobs in its medical-devices division.
Medtech, a Montpellier, France-based surgical robotic company, named Teresa Prego its marketing director.
NuVasive expects 2015 revenue to reach $811 million, a 6 percent increase from 2014.
OrthAlign successfully completed its limited release phase of OrthAlign Plus for total hip arthroplasty use in the direct anterior hip approach.
OsteoVantage was awarded a Small Business Innovation and Research Phase I grant by the National Science Foundation.
San Jose, Calif.-based SI-BONE expanded its presence in Europe with the creation of SI-BONE UK, to be based in Knaresborough, North Yorkshire, United Kingdom.
MidCap Business Credit completed a $6 million asset-based line of credit to Boston-based SpineFrontier.
Needham has downgraded Stryker stock to a "hold" rating.
VGI Medical received FDA 510(k) clearance to market its VerteLP Lateral Lumber Cage System.